Coronavirus India | BMC hasn’t paid 144 Mumbai nurses on COVID-19 duty since May

The 144 young nurses on coronavirus duty were supposed to get paid a daily allowance of Rs 300 for working in the COVID-19 wards along with their salaries, but they haven't received any payment, nor have they got their appointment letters

Moneycontrol News

July 27, 2020 / 10:38 PM IST

Representational Image (PTI)

The Brihanmumbai Municipal Corporation has not paid the salaries of as many as 144 nurses who are presently on COVID-19 duty across coronavirus wards in Mumbai.

The 144 young nurses on coronavirus duty were supposed to get paid a daily allowance of Rs 300 for working in the COVID-19 wards along with their salaries. All BMC staff on COVID-19 duty are supposed to get the allowance, but these nurses have claimed they have not been paid at all since they were hired in May.

These newly hired nurses on coronavirus duty have been working for nearly eight hours daily. Most of them are aged between 26 and 28 years and have been put up at hostels or BMC accommodations, reported the Mumbai Mirror.

An India Today report states that they have already written to the Mumbai civic body to seek clarity on the nature of their employment (whether it is permanent or contractual) and also their dues.

The Municipal Mazdoor Union has informed that these nurses have not received their appointment letters from the BMC yet. They had applied for jobs in 2018 and got a call from BMC in May 2020 asking them to submit their personal documents for verification. The civic body has reportedly not been able to formalise their appointment because their caste documents need to be verified as there are caste-based reservations in the jobs.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show